Urinary wicking devices now have options for both sleeping and daytime activities. Share on Pinterest Wicking is the act of absorbing or drawing liquid away. Urinary wicking devices are medical ...
From the Uresta Starter Kit, a woman selects one of the bladder support device sizes to find her best fit for comfort and effectiveness. A femtech startup is bringing a non-surgical solution for women ...
Please provide your email address to receive an email when new articles are posted on . A digital intravaginal device for pelvic floor muscle training improved urinary incontinence symptoms and ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific said Monday it has agreed to acquire ...
Relief Srl raised more than €1 million (US$1.08 million) in financing for Urorelief, its endourethral medical device which treats stress urinary incontinence. The Italian startup will use the funds to ...
The FDA has given marketing approval to a new implant aimed at treating urinary incontinence. The device focuses on reducing barriers to treatment for patients. Experts say that this product is ...
Female Stress Urinary Incontinence Treatment Devices Market · GlobeNewswire Inc. Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Female Stress Urinary Incontinence Treatment Devices Market - Global ...
Your urinary sphincter is the muscle that controls urine flow from your bladder. An artificial urinary sphincter (AUS) is a device that takes over the work of a non-functioning urinary sphincter. This ...
After implantation, patients are able to return home with the therapy activated; no daily interventions or manual adjustments are required. The Food and Drug Administration (FDA) has cleared Medtronic ...
The electronic device was successfully implanted and activated in 6 men with SUI who experienced reduction in pad usage over 1 year. “The results of this first in human study demonstrate that the ...
MINNEAPOLIS--(BUSINESS WIRE)--Uromedica, Inc. announces the initiation of its FDA Investigational Device Exemption trial for ACT® to evaluate its safety and efficacy for treatment of female SUI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results